Heart EXPAND Continued Access Protocol
Public ClinicalTrials.gov record NCT03835754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Heart Expand Continued Access Protocol
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The OCS™ Heart System will be used to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria for transplantation in this continued access protocol.
Study identification
- NCT ID
- NCT03835754
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2019
- Primary completion
- Sep 14, 2021
- Completion
- Aug 11, 2022
- Last update posted
- Jan 16, 2025
2019 – 2022
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai | Los Angeles | California | 90211 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | — |
| AdventHealth Orlando | Orlando | Florida | 32803 | — |
| St. Vincent Cardiovascular Research Institute | Indianapolis | Indiana | 46260 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Minneapolis Heart Institute | Minneapolis | Minnesota | 55407 | — |
| Nyph/Cumc | New York | New York | 10032 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Vanderbilt Medical Center | Nashville | Tennessee | 37232 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03835754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 16, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03835754 live on ClinicalTrials.gov.